Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CYLD decreases the amount of UL83. 1 / 1

| 1

➶

reach

"As shown in XREF_FIG, the si-miR, CYLD, si-miR + NC4 and si-miR + si-C groups exhibited significantly higher apoptotic rates, as well as increased Bax, cleaved caspase-3 and p-IkappaBalpha and IkappaBalpha expression levels, and decreased Bcl-2 and p-p65 and p65 levels compared with the BC group."

32901872

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...